5 - 6 November 2018, London
The 36th Financial Times Annual Global Pharmaceutical and Biotechnology Conference, brings together the industry’s top executives and visionaries to explore the latest trends impacting the global life sciences industry, including the latest trends in gene-based therapies, the rise of China, big data and AI.
As a lead sponsor, ICON is pleased to offer clients and other third parties, a 25% discount of the registration fee (a saving of £475 off the full registration price of £1,899).
President of ICON Clinical Services
Dr. Nuala Murphy will deliver a keynote speech.
Senior Vice President, Drug Development Services & Consulting
Dr. Colin Orford will patricpate in a panel discussion: Innovate Like a Start-Up: A New Future for R&D?
What are the challenges facing R&D, and the strategies and approaches to reinvigorate drug development and research?
Just some of the industry’s leading executives participating include: